Maternal hyperoxygenation during pregnancy as a tool in fetal disease diagnosis and treatment

Agnieszka Zalinska; Maria Respondek-Liberska; Maciej Slodki

doi:10.1002/jcu.23347

Maternal hyperoxygenation during pregnancy as a tool in fetal disease diagnosis and treatment

J Clin Ultrasound. 2023 Feb;51(2):273-282. doi: 10.1002/jcu.23347.

Authors

Agnieszka Zalinska^{1

2}, Maria Respondek-Liberska^{1

3}, Maciej Slodki^{1

4}

Affiliations

¹ Department of Prenatal Cardiology, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.
² Department of Obstetrics and Perinatology, Chair of Obstetrics, Gynecology and Oncological Gynecology, Medical University of Lodz, Lodz, Poland.
³ Department of Diagnosis and Prevention of Fetal Malformations, Medical University of Lodz, Lodz, Poland.
⁴ Faculty of Health Sciences, The Mazovian State University, Plock, Poland.

PMID: 36785501
DOI: 10.1002/jcu.23347

Abstract

Maternal hyperoxygenation (MHO) consists of giving pregnant women (60% to 100%) oxygen through a facemask and using ultrasound assess or monitor the influence on fetal cardiovascular circulation. This review discusses the findings and the utility of acute and chronic MHO in various fetal diseases.

Keywords: chronic MHO; fetal cardiovasular circulation; maternal hyperoxygenation.

Publication types

Review

MeSH terms

Female
Fetal Diseases* / diagnostic imaging
Fetal Diseases* / therapy
Fetus* / blood supply
Humans
Lung
Oxygen / therapeutic use
Pregnancy
Prenatal Diagnosis

Substances

Oxygen